Back to top
more

Align Technology (ALGN)

(Real Time Quote from BATS)

$211.96 USD

211.96
446,774

+1.18 (0.56%)

Updated Nov 5, 2024 03:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Bruker Grows on NMR & Nano Businesses amid Several Odds

On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.

    Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)

    Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.

      Cardiovascular Systems Innovation On Track, Competition Rife

      On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

        Here's Why You Should Bet on Humana (HUM) Stock Right Now

        Louisville-based Humana Inc. (HUM), one of the largest health care plan providers in the United States, has been an investor favorite, given its strong fundamentals

          Medtronic SureTune3 Obtains Health Canada License for DBS

          Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).

            Boston Scientific Wins CE Mark for Vercise Gevia DBS System

            Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.

              HealthEquity (HQY) Q1 Earnings and Revenues Beat Estimates

              HealthEquity Inc (HQY) reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents.

                Amedisys (AMED) Prospects Impressive Amid Tough Competition

                On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).

                  Abiomed (ABMD) at 52-Week High: What's Driving the Stock?

                  Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.

                    Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval

                    Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).

                      Tenet Healthcare Prices New Notes to Repay Existing Debts

                      Tenet Healthcare Corporation (THC) recently priced the previously announced private offering of newly issued notes.

                        QIAGEN Strengthens Cancer Research Foothold on New License

                        QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.

                          Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive

                          Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test.

                            Align Sets Up Manufacturing Center in China, Grows in APAC

                            Align Technology (ALGN) has recently inaugurated a new Invisalign treatment planning facility in Chengdu, China.

                              Abbott Laboratories at 52-Week High on Product Line, Buyouts

                              Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.

                                QIAGEN & Bristol-Myers Squibb Partner on Cancer Research

                                QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.

                                  David Bartosiak headshot

                                  Five Stocks Rocketing Higher on Huge Momentum

                                  The bears were sent running, screaming towards their caves today as the market started strong and didn???t look back at all

                                    Align Technology Upgrades iTero Element Intraoral Scanners

                                    Based in California, leading dental product maker Align Technology, Inc. (ALGN) recently announced a software upgrade to its iTero Element intraoral scanners.

                                      UnitedHealth Unit Taps Connecticut Orthopedic Surgery Market

                                      Surgical Care Affiliates, Inc, a part of UnitedHealth Group's Optum unit, recently partnered with Western Connecticut Orthopedic Surgery Center by making an equity investment in the latter.

                                        Why WellCare (WCG) Stock Should Be in Your Portfolio Now

                                        Leading managed care company WellCare Health Plans, Inc.'s (WCG) business strategies should continue to support growth.

                                          Align Technology Rises with Invisalign, SmartTrack Patents

                                          Align Technology (ALGN) has received two U.S. Patents from the United States Patent and Trademark Office (USPTO) for its SmartTrack clear aligner material.

                                            Quest Diagnostics Poised on Solid Q1 Results Despite Woes

                                            On May 22, we issued an updated research report on Quest Diagnostics, Inc. (DGX), a major commercial laboratory services provider.

                                              Medtronic (MDT) RESOLUTE ONYX Meets Primary Study Endpoint

                                              Medtronic plc (MDT) recently announced favorable outcome on its Resolute Onyx Drug-Eluting Stent.

                                                Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive

                                                Edwards Lifesciences Corporation (EW) recently unveiled positive one-year data on its SAPIEN 3 transcatheter heart valve.

                                                  Is the Time Ripe to Invest in Paylocity Holding (PCTY)?

                                                  If you are planning your portfolio, then Paylocity Holding Corporation (PCTY) can be a wise pick.